Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...

Learn more about whether Relay Therapeutics, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ ...

The Osteosarcoma market presents opportunities in developing novel therapies, with over 25 companies working on 32+ drugs in the pipeline. There is strong focus on Phase III products like HS-20093, ...

Dr Ray O’Connor takes a look at recent clinical papers on myelofibrosis, including the efficacy of Ruxolitinib based ...

Remibrutinib showed early improvements in disease symptoms, sleep, and daily functioning in patients with chronic spontaneous urticaria (CSU) who continued to have symptoms despite receiving ...

July sits at the heart of the Italian summer and is traditionally the month packed with open-air events: fireworks over the ...

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...